Comparison Tool

COMPARISON TOOL

Compare Tool For schools

Compare schools side by side to find the right school for you! Add up to three schools to compare innovation, access, empowerment and transparency.

Schools you’ve selected to compare:

    CLEAR ALL

    Innovation

    Section Score

    Section Grade

    Canadian Institute of Health Research (CIHR) Funding

    What percentage of the University’s total CIHR research funding in the last 2 fiscal years is allocated to global health research?

    What percentage of the University’s total CIHR research funding in the last 2 fiscal years is allocated to rare disease research? (rare diseases are defined as any disease, disorder, illness or condition affecting about 40-50/100,000 people)

    What percentage of the University’s total CIHR research funding in the last 2 fiscal years is allocated to neglected disease (ND) research and diseases with neglected aspects including HIV/AIDS, Tuberculosis, Malaria, etc. research?

    What percentage of the University’s total CIHR research funding in the last 2 fiscal years is allocated to emerging infectious disease research?

    Noncommunicable Disease Research

    How many noncommunicable diseases (NCD) research grants (or other similar grants that aim to award projects focused on underserved Canadian populations) has the university been awarded in the last 2 calendar years? Please specify the name of each grant received, if multiple were received, and the amount of each.

    Publications

    What percentage of the university's medical PubMed publications in the last 2 calendar years (January 1st, 2019 - December 41s, 2020) are focused on global health?

    What percentage of the university's medical PubMed publications in the last 2 calendar years (January 1st, 2019 - December 41s, 2020) are focused on public health strategy?

    What percentage of the university's medical PubMed publications in the last 2 calendar years (January 1st, 2019 - December 41s, 2020) are focused on neglected diseases, HIV, TB, malaria, antimicrobial resistance, and/or access to medicines in low- and middle-income countries?

    What percentage of the university's medical PubMed publications in the last 2 calendar years (January 1st, 2019 - December 41s, 2020) are focused on indigenous health?

    Alternative Models of Biomedical Research

    Is any of the university’s medical research being done in collaboration with, funded by, or driven by alternative models for research and development? (e.g Drug Discovery and Data-Sharing platforms, Prizes, Philanthropy for Drug Discovery, Drug Patent Pools, Public-Private-Partnerships etc.)

    Global Drug Pricing Research

    Is the University currently engaged in or supporting research on global drug pricing mechanisms to ensure equitable access to affordable medicines, or has research in this area been carried out? Examples of types of initiatives provided.

    Neglected Diseases

    Does the university have, or plan to open, a research center or institute dedicated specifically to neglected diseases, HIV/AIDS, TB, Malaria and/or antimicrobial resistance (AMR)?

    Indigenous Health Research

    Does the university have, or plan to open, a research center or institute dedicated specifically to indigenous medical or health research?

    details

    Access

    Section Score

    Section Grade

    Commitment to Health Access

    Has the university officially and publicly committed to licensing its medical discoveries in ways that promote access and affordability for resource-limited populations? If agreements were agreed upon to promote equitable licensing practices, please name them.

    Does the website of the university's technology transfer office (TTO) make an effort to disclose, explain and promote access licensing commitments and practices?

    Open Access

    Has the university adopted initiatives or policies supporting open access publications (EXCLUDING STATEMENTS REGARDING COVID-19)?

    Open Access Publications

    What percentage of the university's total medical sciences publication output is published in open-access publications?

    Non-Exclusive Licensing

    In the past 2 calendar years, what percentage of the university’s total research licenses were non-exclusive? (EXCLUDING COVID-19 RELATED LICENSES)

    In the past 2 calendar years, what percentage of the university’s health technology licenses were non-exclusive?

    LMIC Patents

    In the past 2 calendar years, for what percentage of all health technologies did the university seek patents in low- and lower-middle-income countries as defined by the World Bank?

    In the past 2 calendar years, for what percentage of all health technologies did the university seek patents in upper-middle-income countries as defined by the World Bank?

    Access to Research

    In the past 2 calendar years, what percentage of the university’s exclusive licenses of health technologies included provisions to promote access to those technologies in low- and middle-income countries as defined by the World Bank?

    In the past 2 calendar years, what percentage of the university’s exclusive licenses of health technologies included provisions to promote access to those technologies in high-income countries as defined by the World Bank?

    Best Practices

    Has the university shared its best practices for promoting access to medicines through licensing in the past 2 calendar years?

    Alternative Research and Development Models

    Has the university publicly stated the existence/effectiveness of alternative models of research and development as being important to ensuring access to medical innovation?

    Patent Pools

    Has the university submitted a patent(s) recently (after 2010) to the Medicines Patent Pool (MPP) or World Intellectual Property Organization (WIPO) for protected intellectual property status for medicines treating HIV, hepatitis C, malaria, tuberculosis, neglected diseases, or other patented essential medicines in low- and middle-income countries?

    details

    Empowerment

    Section Score

    Section Grade

    Global Health Education

    Does the university offer its students access to global health engagement and/or education? [As indicated by the existence of a university center/institute, department, and/or non-degree program in global health.]

    Does the university offer its students access to global health engagement and/or education? [As indicated by the existence of a university center/institute, department, and/or non-degree program in global health.]

    EQ2

    Did the university offer courses in the last 2 academic years that address the policy and legal context of biomedical R&D, and more specifically the impact of intellectual property policies, on research priorities and global access to medical innovations?

    Is/are the course(s) required for any major programs?

    Did the university offer courses in the last 2 academic years that address the prevalence of and/or lack of research on neglected diseases, including neglected aspects HIV, TB, and/or malaria?

    Is/are the course(s) required for any major programs?

    Did the university training opportunities (courses, conferences, seminars, etc.) for students and faculty on cultural sensitivity and/or decolonized approaches to global health?

    Is/are the course(s) required for any major programs?

    Indigenous Engagement

    Does the university have programs to maximize Indigenous student enrollment in health related programs? If applicable, please describe the program.

    Conference or Convening

    Has the university hosted a major (in person or remote) conference, symposium or campus-wide event in the past 2 academic years on: Part A: The policy and legal context of biomedical R&D, specifically the impact of intellectual property rights on research priorities and global access to medical innovations? If the university has hosted multiple events for this category, please specify how many; Part B: Neglected diseases, HIV, TB, and/or malaria, and health needs of low- and middle-income countries? If the university has hosted multiple events for this category, please specify how many; Part C: Promoting drug access for low income populations in high income countries? If the university has hosted multiple events for this category, please specify how many.

    Global Partnerships

    Is the university formally involved in a global health partnership with one or more universities based in low- and middle-income countries?

    Learning about Alternative R&D

    Does the university offer any of its students an opportunity to learn more about alternative models for research and development through courses, workshops, or other opportunities?

    details

    Transparency

    Section Score

    Section Grade

    Responsiveness

    How responsive was the university's Technology Transfer Office (TTO) to emails from UAEM regarding the section surveys?

    Access data in the Public Domain

    For questions relying on public data (CATEGORY 1) in the Access section, was sufficient information available in public sources/databases?

    For questions relying on public data (CATEGORY 1) in the Innovation section, was sufficient information available in public sources/databases?

    For questions relying on public data (CATEGORY 1) in the Empowerment section, was sufficient information available in public sources/databases?

    For questions relying on public data (CATEGORY 1) in the COVID-19 section, was sufficient information available in public sources/databases?

    Discrepancies

    How much discrepancy exists between university responses in the submitted forms and what is being internally collected using publicly available data for Category 1 and 2 questions?

    Clinical Trial Data Transparency

    What percent of all of the university’s clinical trial data was published during the last 2 calendar years?

    Publishing Clinical Trial Data

    In the past 4 calendar years, what percentage of completed clinical trials conducted by the university and registered on ClinicalTrials.gov had their data shared as summary results on ClinicalTrials.gov or PubMed?

    Clinical Trial Policy

    Does the university have policies that mandate that all university researchers publish all results of all clinical trials? Y/N. If so, please provide the university’s policy or examples of the university’s policy.

    Prospective Registration

    Do you recommend or require your researchers to prospectively register all clinical trials with an appropriate registry before any subject is enrolled?

    Public Acknowledgement: Clinical Trials

    Does the university publicly acknowledge the need to be transparent in clinical trial results? If yes, check all that apply.

    Private Companies' Involvement in Clinical Trials

    Does the university engage in commissioned research from private companies? Y/N

    Do these companies have the ability to insert clauses affecting or preventing data publication? Y/N

    Conflict of Interest

    Does the university have clear guidelines, or policies, for conflict of interest regarding partnerships with industry with a potential for commercial interest?

    details

    Covid19

    Section Score

    Section Grade

    CQ2-a

    Has the University signed on to the Open Covid Pledge or signed a similar agreement regarding intellectual property for the COVID-19 pandemic? Please specify which agreement the university is a signatory for.

    CQ3

    Has the University made agreements on COVID-19 research/technology licensing with private companies? If yes, is the license exclusive or non-exclusive? If possible, please provide sample language from the licensing agreement.

    CQ4

    What percentage of the University’s publications on COVID-19 biomedical research are available open access (from March 2020 - March 2021)?

    CQ5

    Has the university hosted a (remote) conference, symposium or event in the last 12 months on COVID-19 needs of low- and middle-income countries?

    Has the university hosted a (remote) major conference, symposium, or event in the last 12 months on biomedical COVID-19 related challenges/solutions for populations with historically low access to medicines, including Indigenous communities, within high-income countries such as Canada and the United States?

    CQ6

    Has the University translated its COVID-19 public health strategy research findings into practical resources that are available and accessible to indigenous communities? If yes, please provide examples.

    If yes, how many languages are the resources accessible in?

    details

    Total

    Overall Score

    Percentage

    Overall Grade

    Add a school:

    Add a school:

    Add a school:

    Canadian universities play a critical role in addressing global challenges such as HIV/AIDS, Tuberculosis, and other neglected diseases.

    Facebook Twitter Instagram
    Quick LinkS
    Privacy Links
    Contact us

    Copyright © 2023 globalhealthgrades